BeOne Medicines
ONC
#622
Rank
HK$304.17 B
Marketcap
HK$2,749
Share price
1.62%
Change (1 day)
58.36%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Sustainability Reports

Thumbnail BeOne Medicines Sustainability Report 2023

Sustainability Report 2023

Language: English

View Sustainability Report
Thumbnail BeOne Medicines Sustainability Report 2020

Sustainability Report 2020

Language: English

View Sustainability Report